Reducing Recurrence of C. difficile Infection

This publication has 10 references indexed in Scilit:

• Bezlotoxumab for Prevention of RecurrentClostridium difficileInfection
  New England Journal of Medicine, 2017
• Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin
  Antimicrobial Agents and Chemotherapy, 2016
• Burden ofClostridium difficileInfection in the United States
  New England Journal of Medicine, 2015
• Mechanisms of Protection against Clostridium difficile Infection by the Monoclonal Antitoxin Antibodies Actoxumab and Bezlotoxumab
  Infection and Immunity, 2015
• Attributable Inpatient Costs of RecurrentClostridium difficileInfections
  Infection Control & Hospital Epidemiology, 2014
• Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study
  BMC Infectious Diseases, 2014
• Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography
  Journal of Biological Chemistry, 2014
• Toward a structural understanding of Clostridium difficile toxins A and B
  Frontiers in Cellular and Infection Microbiology, 2012
• Historical Perspectives on Studies ofClostridium difficileandC. difficileInfection
  Clinical Infectious Diseases, 2008
• Clindamycin-Associated Colitis Due to a Toxin-Producing Species of Clostridium in Hamsters
  The Journal of Infectious Diseases, 1977